Late recurrence of stage I malignant mel
β
Mordechai Gutman; Joseph M. Klausner; Moshe Inbar; Ron R. Rozin
π
Article
π
1989
π
John Wiley and Sons
π
English
β 250 KB
Although the introduction of well-established risk factors has made the clinical course and prognosis of malignant melanoma disease much more predictable, in a considerable number of patients the disease's course is still not as expected. One group to which this applies are stage I melanoma patients